Background: Bisphosphonates are considered to be effective in preventing tumor metastasis to bone. Urokinase-type plasminogen activator (uPA) is thought to be critically involved in the metastatic phenotype of prostate cancer. In this study, we examined the effect of pamidronate on uPA expression in PC-3 prostate cancer cells. MATERIALS AND: The mRNA expression of uPA was assayed by real-time RT-PCR. The transcriptional activity of uPA was measured by a luciferase assay.

Results: Pamidronate inhibited uPA mRNA expression by about 90% at 24 h. The inhibition of uPA mRNA expression was prevented in part by cotreatment with geranylgeranyl diphosphate (GGPP). Moreover, GGTI-286, a selective inhibitor of geranylgeranyl transferase, also inhibited uPA mRNA expression. The luciferase activity of uPA reporter plasmid was significantly inhibited by pamidronate.

Conclusion: These results indicate that the decrease in uPA expression brought about by pamidronate is dependent on the inhibition of geranylgeranylation of proteins and occurs at the transcriptional level.

Download full-text PDF

Source

Publication Analysis

Top Keywords

mrna expression
16
prostate cancer
12
upa mrna
12
upa
9
urokinase-type plasminogen
8
plasminogen activator
8
expression pc-3
8
pc-3 prostate
8
cancer cells
8
upa expression
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!